In the third episode of the podcast “DiGA – wohin geht die Reise?“, leading experts discuss the current challenges in the field of digital health applications (DiGA).
A central topic of the episode: from January 2025, around 85 percent of insured persons could be excluded from using DiGA before these are even established across the board. The reason is a new technical concept from gematik, which provides for DiGA to be prescribed exclusively via the e-prescription app in future.
Alongside the question of access, the pricing of DiGA is also examined in detail: why are DiGA expensive, and to what extent are these prices justified? Malte Bucksch, managing director of the company, provides valuable insights from the manufacturers’ perspective.
To the LinkedIn post: Click here
The episode is available online at: https://medicathek.de/video/digatalk-folge-3/ (login required)
Henrik Emmert and Malte Bucksch (r.) on the “DiGA Talk” podcast.